SEK 174.85
(2.01%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 6.41 Billion SEK | 2.95% |
2022 | 6.23 Billion SEK | 30.73% |
2021 | 4.76 Billion SEK | 5.63% |
2020 | 4.51 Billion SEK | -3.79% |
2019 | 4.69 Billion SEK | 3.24% |
2018 | 4.54 Billion SEK | -6.87% |
2017 | 4.87 Billion SEK | -10.16% |
2016 | 5.43 Billion SEK | 0.41% |
2015 | 5.4 Billion SEK | 3.13% |
2014 | 5.24 Billion SEK | 23.3% |
2013 | 4.25 Billion SEK | 4.78% |
2012 | 4.06 Billion SEK | 5.81% |
2011 | 3.83 Billion SEK | 6.02% |
2010 | 3.61 Billion SEK | -12.92% |
2009 | 4.15 Billion SEK | 3.51% |
2008 | 4.01 Billion SEK | 37.83% |
2007 | 2.91 Billion SEK | 39.85% |
2006 | 2.08 Billion SEK | -3.41% |
2005 | 2.15 Billion SEK | 24.7% |
2004 | 1.72 Billion SEK | -1.94% |
2003 | 1.76 Billion SEK | 7.63% |
2002 | 1.63 Billion SEK | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 7.12 Billion SEK | 11.02% |
2024 Q3 | 7.25 Billion SEK | 0.64% |
2024 Q2 | 7.21 Billion SEK | 1.25% |
2023 Q3 | 7.23 Billion SEK | 0.17% |
2023 Q1 | 6.78 Billion SEK | 8.91% |
2023 Q2 | 7.22 Billion SEK | 6.45% |
2023 FY | 6.41 Billion SEK | 2.95% |
2023 Q4 | 6.41 Billion SEK | -11.34% |
2022 Q2 | 5.9 Billion SEK | 11.54% |
2022 Q3 | 6.46 Billion SEK | 9.46% |
2022 FY | 6.23 Billion SEK | 30.73% |
2022 Q4 | 6.23 Billion SEK | -3.62% |
2022 Q1 | 5.29 Billion SEK | 11.1% |
2021 Q1 | 4.8 Billion SEK | 6.47% |
2021 Q4 | 4.76 Billion SEK | -5.19% |
2021 Q3 | 5.02 Billion SEK | 3.63% |
2021 FY | 4.76 Billion SEK | 5.63% |
2021 Q2 | 4.85 Billion SEK | 0.98% |
2020 Q2 | 5.62 Billion SEK | 3.08% |
2020 Q4 | 4.51 Billion SEK | -21.34% |
2020 FY | 4.51 Billion SEK | -3.79% |
2020 Q1 | 5.46 Billion SEK | 16.39% |
2020 Q3 | 5.73 Billion SEK | 1.94% |
2019 Q4 | 4.69 Billion SEK | -14.29% |
2019 FY | 4.69 Billion SEK | 3.24% |
2019 Q3 | 5.47 Billion SEK | 4.03% |
2019 Q2 | 5.26 Billion SEK | 3.1% |
2019 Q1 | 5.1 Billion SEK | 12.3% |
2018 Q2 | 5.68 Billion SEK | 1.77% |
2018 Q3 | 5.39 Billion SEK | -5.22% |
2018 FY | 4.54 Billion SEK | -6.87% |
2018 Q4 | 4.54 Billion SEK | -15.73% |
2018 Q1 | 5.59 Billion SEK | 14.57% |
2017 Q1 | 6 Billion SEK | 10.57% |
2017 Q4 | 4.87 Billion SEK | -20.96% |
2017 Q3 | 6.17 Billion SEK | -0.24% |
2017 Q2 | 6.18 Billion SEK | 3.05% |
2017 FY | 4.87 Billion SEK | -10.16% |
2016 Q4 | 5.43 Billion SEK | -11.53% |
2016 Q3 | 6.13 Billion SEK | 4.12% |
2016 Q1 | 5.57 Billion SEK | 2.98% |
2016 FY | 5.43 Billion SEK | 0.41% |
2016 Q2 | 5.89 Billion SEK | 5.85% |
2015 Q1 | 5.86 Billion SEK | 11.88% |
2015 FY | 5.4 Billion SEK | 3.13% |
2015 Q4 | 5.4 Billion SEK | -12.5% |
2015 Q3 | 6.18 Billion SEK | 5.12% |
2015 Q2 | 5.88 Billion SEK | 0.22% |
2014 Q2 | 5.06 Billion SEK | 9.03% |
2014 Q1 | 4.64 Billion SEK | 9.12% |
2014 FY | 5.24 Billion SEK | 23.3% |
2014 Q4 | 5.24 Billion SEK | -3.74% |
2014 Q3 | 5.44 Billion SEK | 7.67% |
2013 Q3 | 4.56 Billion SEK | 1.51% |
2013 Q2 | 4.49 Billion SEK | 4.29% |
2013 Q1 | 4.31 Billion SEK | 6.23% |
2013 FY | 4.25 Billion SEK | 4.78% |
2013 Q4 | 4.25 Billion SEK | -6.83% |
2012 Q1 | 4.02 Billion SEK | 4.95% |
2012 Q2 | 4.29 Billion SEK | 6.73% |
2012 Q3 | 4.44 Billion SEK | 3.33% |
2012 FY | 4.06 Billion SEK | 5.81% |
2012 Q4 | 4.06 Billion SEK | -8.58% |
2011 Q1 | 3.78 Billion SEK | 4.56% |
2011 Q4 | 3.83 Billion SEK | -11.3% |
2011 FY | 3.83 Billion SEK | 6.02% |
2011 Q3 | 4.32 Billion SEK | 8.5% |
2011 Q2 | 3.98 Billion SEK | 5.36% |
2010 Q1 | 4.24 Billion SEK | 2.24% |
2010 FY | 3.61 Billion SEK | -12.92% |
2010 Q4 | 3.61 Billion SEK | -10.53% |
2010 Q3 | 4.04 Billion SEK | -7.71% |
2010 Q2 | 4.38 Billion SEK | 3.15% |
2009 Q4 | 4.15 Billion SEK | 0.0% |
2009 FY | 4.15 Billion SEK | 3.51% |
2008 FY | 4.01 Billion SEK | 37.83% |
2007 FY | 2.91 Billion SEK | 39.85% |
2006 FY | 2.08 Billion SEK | -3.41% |
2005 FY | 2.15 Billion SEK | 24.7% |
2004 FY | 1.72 Billion SEK | -1.94% |
2003 FY | 1.76 Billion SEK | 7.63% |
2002 FY | 1.63 Billion SEK | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Acarix AB (publ) | 6.83 Million SEK | -93714.885% |
ADDvise Group AB (publ) | 121.2 Million SEK | -5193.729% |
ADDvise Group AB (publ) | 121.2 Million SEK | -5193.729% |
Arcoma AB | 28.02 Million SEK | -22792.211% |
Bactiguard Holding AB (publ) | 29.64 Million SEK | -21542.043% |
BICO Group AB (publ) | 493.1 Million SEK | -1201.156% |
Boule Diagnostics AB (publ) | 62.4 Million SEK | -10182.051% |
CellaVision AB (publ) | 126.03 Million SEK | -4990.528% |
Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -104822.322% |
Chordate Medical Holding AB (publ) | 1.77 Million SEK | -362197.358% |
C-Rad AB (publ) | 64.09 Million SEK | -9909.361% |
Duearity AB (publ) | 4.15 Million SEK | -154167.853% |
Dignitana AB (publ) | 7.41 Million SEK | -86450.654% |
Episurf Medical AB (publ) | 3.7 Million SEK | -173305.405% |
Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 381239.986% |
Iconovo AB (publ) | -4.86 Million SEK | 132062.155% |
Integrum AB (publ) | 22.36 Million SEK | -28591.601% |
Luxbright AB (publ) | 8000.00 SEK | -80199900.0% |
Mentice AB (publ) | 14.1 Million SEK | -45390.641% |
OssDsign AB (publ) | 4.3 Million SEK | -148970.632% |
Paxman AB (publ) | 19.99 Million SEK | -31981.604% |
Promimic AB (publ) | 330 Thousand SEK | -1944142.424% |
Qlife Holding AB (publ) | 7.29 Million SEK | -87886.835% |
SciBase Holding AB (publ) | 11.91 Million SEK | -53730.019% |
ScandiDos AB (publ) | 22.69 Million SEK | -28176.774% |
Sectra AB (publ) | 36.59 Million SEK | -17434.846% |
Sedana Medical AB (publ) | 42.97 Million SEK | -14829.61% |
Senzime AB (publ) | 20.34 Million SEK | -31443.756% |
SpectraCure AB (publ) | 1.00 SEK | -641599999900.0% |
Stille AB | 66.55 Million SEK | -9540.437% |
Vitrolife AB (publ) | 413 Million SEK | -1453.511% |
Xvivo Perfusion AB (publ) | 141.6 Million SEK | -4430.945% |